LS Lobe Sciences Ltd. Stock: price and directors' dealings · Canada · SEDISource id SEDI:lobe-sciences-ltd CA · SEDI Mcap US$19M Follow the Lobe Sciences Ltd. share price and the full insider trade history of the company, a listed issuer based in Canada. Shares are listed on the CA market, under the supervision of SEDI. Market capitalisation: €19m. The latest transaction was filed on 8 September 2026 (46 - Compensation for services). Among the most active insiders: Mastrodonato, Marco. The full history is free.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 September 2026
All Executives67 Thresholds0 Prospectus0 Other0
Declarations 67 total
● 4 - Director of Issuer · Executives · 12 Aug 2025
8,535,625 shares Common Shares SEDI:4774612 ● 4 - Director of Issuer · Executives · 1 Sept 2025
Common Shares SEDI:4590362 ▲ 4 - Director of Issuer · Executives · 8 Sept 2022
340,000 shares Common Shares SEDI:4774598 Canonical exit: 7 Dec 2022 (T+90) ● 4 - Director of Issuer · Executives · 9 Jun 2026
1,176,998 shares Common Shares SEDI:4774595 ● 4 - Director of Issuer · Executives · 9 Jun 2026
1,333,333 shares Common Shares SEDI:4774590 ▲ 4 - Director of Issuer · Executives · 21 Mar 2025
50,000 shares Common Shares SEDI:4774587 Canonical exit: 19 Jun 2025 (T+90) ▲ 4 - Director of Issuer · Executives · 19 Mar 2025
80,000 shares Common Shares SEDI:4774586 Canonical exit: 17 Jun 2025 (T+90) ▲ 4 - Director of Issuer · Executives · 18 Mar 2025
139,925 shares Common Shares SEDI:4774583 Canonical exit: 16 Jun 2025 (T+90) ▲ 4 - Director of Issuer · Executives · 17 Mar 2025
204,015 shares Common Shares SEDI:4774576 Canonical exit: 15 Jun 2025 (T+90) ▲ 4 - Director of Issuer · Executives · 28 Feb 2025
50,000 shares Common Shares SEDI:4774575 Canonical exit: 29 May 2025 (T+90) ▲ 4 - Director of Issuer · Executives · 27 Feb 2025
380,206 shares Common Shares SEDI:4774573 Canonical exit: 28 May 2025 (T+90) ● 4 - Director of Issuer · Executives · 31 Aug 2025
3,477,705 shares Common Shares SEDI:4572762 ● 4 - Director of Issuer · Executives · 9 Jun 2026
3,510,331 shares Common Shares SEDI:4774520 ● 4 - Director of Issuer · Executives · 4 Feb 2025
2,333,333 shares Common Shares SEDI:4556358 ● 3 - 10% Security Holder of Issuer · Executives · 25 Aug 2025
3,889,313 shares Common Shares SEDI:4774518 ● 3 - 10% Security Holder of Issuer · Executives · 22 Aug 2025
3,827,381 shares Common Shares SEDI:4774517 ● 3 - 10% Security Holder of Issuer · Executives · 31 Mar 2025
Common Shares SEDI:4774516 ● 5 - Senior Officer of Issuer · Executives · 1 Aug 2026
35,854,759 shares Common Shares SEDI:4759778 ● 5 - Senior Officer of Issuer · Executives · 1 Aug 2026
Common Shares SEDI:4759777 ● 5 - Senior Officer of Issuer · Executives · 24 Jul 2026
1,375,000 shares Restricted Share Units SEDI:4757693 ● 5 - Senior Officer of Issuer · Executives · 24 Jul 2026
6,414,599 shares Common Shares SEDI:4757692 ● 3 - 10% Security Holder of Issuer · Executives · 24 Jul 2026
16,649,419 shares Common Shares SEDI:4756752 ● 4 - Director of Issuer · Executives · 24 Jul 2026
3,500,000 shares Restricted Share Units SEDI:4756750 ● 4 - Director of Issuer · Executives · 1 Jan 2026
Restricted Share Units SEDI:4756749 ● 5 - Senior Officer of Issuer · Executives · 24 Jul 2026
2,000,000 shares Restricted Share Units SEDI:4756748 25 of 67 declarations
Load more (42 remaining) About Lobe Sciences Ltd. Lobe Sciences Ltd. is a Toronto Stock Exchange-listed company focused on developing cannabinoid-based treatments. It aims to enhance mental health and well-being through research and innovation.